Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dainippon Sumitomo Pharma Co Ltd's Subsidiary to Acquire Elevation Pharmaceuticals, Inc


Thursday, 30 Aug 2012 08:00pm EDT 

Dainippon Sumitomo Pharma Co Ltd announced that its wholly owned subsidiary, Sunovion Pharmaceuticals Inc., based in United States, has signed an agreement to acquire Elevation Pharmaceuticals, Inc. in the second quarter of fiscal year ending March 2013. 

Related Company News

Company Quote

1270.0
21.0 +1.68%
1:01am EDT